FONT-SIZE Plus   Neg

DexCom Names Kevin Sayer COO - Quick Facts

DexCom, Inc. (DXCM), a medical device company, said it has appointed Kevin Sayer, currently the company's president, as its chief operating officer or COO.

As President, Sayer is responsible for the firm's research and development, manufacturing, clinical, regulatory and finance functions. He will continue to lead these groups, and with the additional responsibility as COO, Sayer will also lead the company's sales, marketing, and other core commercial functions.

DexCom noted that Sayer will continue to report to Terry Gregg, chief executive officer of the company.

Sayer has served as DexCom's president since June 2011, and as a board member since November 2007.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Schaeffler AG, the German auto parts maker owned by the Schaeffler family, Thursday set its initial public offering price at 12.50 euros per share. The company raised gross proceeds of about 938 million euros by offering 75 million shares, of which 66 million from Schaeffler AG and the remaining 9... Dick Costolo, who stepped down as CEO of Twitter in June, is taking a bit of a career turn - to Hollywood. The one-time tech darling left Twitter after 5 years at the helm amid Wall Street concerns about the future of the social media giant. Now he will be consulting on story lines for the HBO series Silicon Valley. Formula One is reportedly near a deal that would sell the racing circuit to an investor group that includes the owner of the Miami Dolphins. The Financial Times reports that the purchase price for the racing company is $8.5 billion. According to the paper, Dolphins owner Stephen Ross has reached a hand-shake agreement with CVC, a private equity firm holding a 35.5 percent stake in Formula One.
comments powered by Disqus
Trade DXCM now with 
Follow RTT